Achiko AG (Achiko AG) Interest Coverage : 0 (At Loss) (As of Jun. 2022)

View and export this data going back to 2020. Start your Free Trial

What is Achiko AG Interest Coverage?

Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income by its Interest Expense. Achiko AG's Operating Income for the six months ended in Jun. 2022 was $-1.92 Mil. Achiko AG's Interest Expense for the six months ended in Jun. 2022 was $-0.52 Mil. did not have earnings to cover the interest expense. The higher the ratio, the stronger the company's financial strength is.

The historical rank and industry rank for Achiko AG's Interest Coverage or its related term are showing as below:

ACHKF's Interest Coverage is not ranked ^*
in the Healthcare Providers & Services industry.
Industry Median: 9.035
* Ranked among companies with meaningful Interest Coverage only.

Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

Achiko AG Interest Coverage Historical Data

The historical data trend for Achiko AG's Interest Coverage can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Note: For Interest Coverage, "No debt" indicates no long-term debt. An indication of "No Debt" does not necessarily mean that the company has no long-term debt obligations; it could be due to missing data in the quarterly or annual report. Use caution when interpreting this information.

* Premium members only.

Achiko AG Interest Coverage Chart

Achiko AG Annual Data

Trend

Dec18

Dec19

Dec20

Dec21

Interest Coverage

No Debt

Achiko AG Semi-Annual Data
	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22
Interest Coverage	Get a 7-Day Free Trial			-	-	-	-	-

Competitive Comparison of Achiko AG's Interest Coverage

For the Health Information Services subindustry, Achiko AG's Interest Coverage, along with its competitors' market caps and Interest Coverage data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Achiko AG's Interest Coverage Distribution in the Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Achiko AG's Interest Coverage distribution charts can be found below:

* The bar in red indicates where Achiko AG's Interest Coverage falls into.

Achiko AG Interest Coverage Calculation

Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income (EBIT) by its Interest Expense:

If Interest Expense is negative and Operating Income is positive, then

Interest Coverage

-1

Operating Income

Interest Expense

Else if Interest Expense is negative and Operating Income is negative, then

The company did not have earnings to cover the interest expense.

Else if Interest Expense is 0 and Long-Term Debt & Capital Lease Obligation is 0, then

The company had no debt ⁽¹⁾.

Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

Achiko AG's Interest Coverage for the fiscal year that ended in Dec. 2021 is calculated as

Here, for the fiscal year that ended in Dec. 2021, Achiko AG's Interest Expense was $-0.62 Mil. Its Operating Income was $-6.76 Mil. And its Long-Term Debt & Capital Lease Obligation was $2.12 Mil.

Achiko AG did not have earnings to cover the interest expense.

Achiko AG's Interest Coverage for the quarter that ended in Jun. 2022 is calculated as

Here, for the six months ended in Jun. 2022, Achiko AG's Interest Expense was $-0.52 Mil. Its Operating Income was $-1.92 Mil. And its Long-Term Debt & Capital Lease Obligation was $3.56 Mil.

Achiko AG did not have earnings to cover the interest expense.

The higher the ratio, the stronger the company's Financial Strength is.

Achiko AG (OTCPK:ACHKF) Interest Coverage Explanation

Ben Graham requires that a company has a minimum interest coverage of 5 with the companies he invested. If the interest coverage is less than 2, the company is burdened by debt. Any business slow or recession may drag the company into a situation where it cannot pay the interest on its debt.

Interest Coverage is an important factor when GuruFocus ranks a company's overage Financial Strength .

Achiko AG Interest Coverage Related Terms

Thank you for viewing the detailed overview of Achiko AG's Interest Coverage provided by GuruFocus.com. Please click on the following links to see related term pages.

Achiko AG (Achiko AG) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Achiko AG (OTCPK:ACHKF) » Definitions » Interest Coverage

Comparable Companies

Traded in Other Exchanges

N/A

Address

Tessinerplatz 7, Zurich, CHE, CH-8002

Website

https://www.achiko.com

Achiko AG is developing disruptive diagnostic solutions that put people first. The company product is a rapid, reliable Covid-19 test with a companion app offering a user-friendly digital health passport. Achiko creates and develops aptamer-based diagnostics through its biotechnology division, AptameX, and companion health apps via its digital mobile health technology division, Teman Sehat. The AptameX DNA aptamer tests can be rapidly chemically synthesized, are cost-effective, and have wide potential across multiple disease diagnostics. Leveraging AptameX and Teman Sehat, Achiko aims to deliver fast, accurate, and affordable diagnostic testing for a range of pathogenic diseases and therapeutic indications in the rapidly evolving healthcare diagnostics field.